Stephens & Co. Upgrades Align Tech to Overweight, Raises Price Target to $700

Stephens & Co. analyst Chris Cooley upgrades Align Tech (NASDAQ:ALGN) from Equal-Weight to Overweight and raises the price target from $600 to $700.

byBenzinga Newsdesk

July 9, 2021

1 minute read

Stephens & Co. analyst Chris Cooley upgrades Align Tech (NASDAQ:ALGN) from Equal-Weight to Overweight and raises the price target from $600 to $700.

Triple H Will Never Wrestle For WWE Again: Here’s Why And A Look At How Successful He Was In The Ring

By Wayne Duggan

Today, 2:18 AM

World Wrestling Entertainment, Inc. (NYSE: WWE) star and executive vice president of global talent strategy & development officially announced his retirement from in-ring performing on Friday.

WWE

Why Sesen Bio Shares Are Trading Lower Today

By Adam Eckert

Today, 2:18 AM

Sesen Bio Inc (NASDAQ: SESN) is trading significantly lower Monday after the U.S. Food and Drug Administration issued a Complete Response Letter for the company's bladder cancer candidate Vicineum.

SESN

B. Riley Securities Initiates Coverage On New Mountain Finance with Neutral Rating, Announces Price Target of $11.5

By Benzinga Newsdesk

Today, 2:18 AM

B. Riley Securities analyst Bryce Rowe initiates coverage on New Mountain Finance (NASDAQ:NMFC) with a Neutral rating and announces Price Target of $11.5.

NMFC

Sotera Health Q2 EPS $0.26 Beats $0.21 Estimate, Sales $252.00M Beat $227.21M Estimate

By Benzinga Newsdesk

Today, 2:18 AM

Sotera Health (NASDAQ:SHC) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.21 by 23.81 percent. The company reported quarterly sales of $252.00 million which beat the

SHC

Stephens & Co. Upgrades Align Tech to Overweight, Raises Price Target to $700

Related Posts

Triple H Will Never Wrestle For WWE Again: Here’s Why And A Look At How Successful He Was In The Ring

Why Sesen Bio Shares Are Trading Lower Today

B. Riley Securities Initiates Coverage On New Mountain Finance with Neutral Rating, Announces Price Target of $11.5

Sotera Health Q2 EPS $0.26 Beats $0.21 Estimate, Sales $252.00M Beat $227.21M Estimate